Infection Clinical Trial
Official title:
Altered Microbiota is Related Increased Infection Rates After Traumatic Splenectomy
Studies has shown an increasingly infection rate after splenectomy, and there is a potential correlation between microbiota and immune system. investigators suppose that increasingly infection can be associated with the alteration composition of the gut microbiota after splenectomy. It's investigators' aim to discover if any difference of gut microbiota is exist in patients who suffer from traumatic splenectomy compared with normal people, ultimately aim toreduce and mitigation infection rate through controlling gut microbiota.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | December 10, 2019 |
Est. primary completion date | November 25, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All the patients underwent an total splenectomy in the First Affiliated Hospital of Harbin Medical University from January 1st, 2015 to May 1st, 2017. Each participant provided a fresh stool sample in hospital when following-up. Exclusion Criteria: - Use antibiotics and probiotics 3 mouth before samples collection. - Other severe abdomen injury - Underwent abdomen organ resection surgery - Other digestive system disease |
Country | Name | City | State |
---|---|---|---|
China | First affiliated hospital of Harbin medical university | Harbin | Heilongjiang |
Lead Sponsor | Collaborator |
---|---|
First Affiliated Hospital of Harbin Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Transcriptional changes in gut microbiota | 16S rRNA gene sequencing will be performed with stander procedure | Baseline, 6 months after surgery, 12 months after surgery, 24 months after surgery | |
Primary | Transcriptional changes in plasma LPS levels | Plasma LPS level will be measured by ELISA | Baseline, 6 months after surgery, 12 months after surgery, 24 months after surgery | |
Secondary | Fecal SIgA | Fecal SIgA antibody will be measured by ELISA | Baseline, 6 months after surgery, 12 months after surgery, 24 months after surgery | |
Secondary | Fecal calprotectin | Fecal SIgA antibody will be measured by ELISA | Baseline, 6 months after surgery, 12 months after surgery, 24 months after surgery | |
Secondary | Plasma DAO | Plasma DAO antibody will be measured by ELISA | Baseline, 6 months after surgery, 12 months after surgery, 24 months after surgery | |
Secondary | Plasma D-Lac | Plasma D-Lac antibody will be measured by ELISA | Baseline, 6 months after surgery, 12 months after surgery, 24 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |